Shire Pharmaceuticals Group PLC
http://www.shire.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Shire Pharmaceuticals Group PLC
IPO Outlook: 2021 Saw Record Numbers But Poor Returns; 2022 Looks Muted
Initial public offering momentum decelerated as stock prices declined last year, but even with lower valuations making M&A more attractive, the IPO market this year is expected to be active.
Deal Watch: Roche, Pfizer, GSK Close Out 2021 With Licensing Transactions
Ahead of the usual flurry of deal-making in January, Roche gets retinal cell therapy candidate from Lineage Cell Therapeutics, Pfizer subsidiary Amplyx licenses antiviral candidate to Vera, and GSK expands neurology tie-up with Ligand.
FDA Slams Citizen Petition: Harsh Language, FTC Referral Suggest Tougher Stance On ANDA Delay Tactics
While the FTC referral is not unique, this seems the first time US FDA has cited intent to delay generic approval as a ground for denying a citizen petition. With Califf's confirmation hearing suggesting some bipartisan consensus on the issue, FDA might soon find itself with new powers.
Ipsen Gives Genfit Liver Drug New Lease Of Life
The French biotech was firmly on the ropes last year after elafibranor joined the long list of failures for NASH but the promise it has shown in primary biliary cholangitis has persuaded Ipsen to part with a hefty upfront fee.
Company Information
- Industry
-
Pharmaceuticals
- Specialty Pharmaceuticals
- Other Names / Subsidiaries
-
- Advanced BioHealing, Inc. (renamed Shire Regenerative Medicine)
- AesRX LLC
- Baxalta Incorporated
- BIKAM Pharmaceuticals Inc.
- Chatham Therapeutics
- Dyax Corp.
- FerroKin BioSciences, Inc.
- Fibrotech Therapeutics
- Foresight Biotherapeutics Inc.
- Gambro AB
- Immuno-US
- Jerini AG
- Lotus Tissue Repair
- Lumena Pharmaceuticals
- Meritage Pharma, Inc.
- Movetis NV
- New Pervasis Therapeutics, Inc.
- NPS Pharmaceuticals, Inc.
- Premacure AB
- Prism Pharmaceuticals, Inc.
- River Pharmaceuticals
- Roberts Pharmaceutical Corporation
- SARcode Corporation
- SuppreMol GmbH
- Synovis Life Technologies, Inc.
- Transkaryotic Therapies, Inc.
- ViroPharma Inc.